15 years of continuous innovation in internal fixation
Sold in countries50
Start of "Quiet Period"
2021 Full-year results
Annual General Meeting 2022
Ad-hoc releases pursuant to art. 53 LR.
All necessary financial information of the company at a glance.
Sales in CHFm
-4% in CHF
+1% in local currencies (131.2 CHFm(1))
EBITDA in CHFm
16% EBITDA margin reported
16% EBITDA margin adjusted(2)
- Solid 1% local growth above the market
- 13% second half year growth in direct markets
- Stable EBITDA margin despite the pandemic
- 27 new jobs added over 12 months
(1) Fx adjusted.
(2) Adjusted - extraordinary impairment on intangible assets of CHF 1.7 million and additional inventory provisions of CHF 0.6 million.
Medartis relies on efficient cooperation between the Board of Directors and the company management. We respect the interests of our shareholders and rely on clear rules in addition to open, transparent corporate communication.
|NAME||POSITION||COMMITTEE MEMBERSHIP||FIRST ELECTED||END CURRENT PERIOD|
|Dr. h.c. Thomas Straumann||Vice Chairman||Member of the SIC||1998||2022||+|
|Dominik Ellenrieder||Member of the Board||Chairman of the HRCC|
Member of the SIC
|Willi Miesch||Member of the Board||Chairman of the SIC||2010||2022||+|
|Dr. Jürg Greuter||Member of the Board||-||1997||2022||+|
|Dr. med. Daniel B. Herren||Member of the Board||Member of the HRCC|
Member of the SIC
|Roland Hess||Member of the Board||Chairman of the FAC||2017||2022||+|
|Damien Tappy||Member of the Board||Member of the HRCC|
Member of the FAC
HRCC = Human Resources and Compensation Committee | FAC = Finance and Audit Committee | SIC = Strategy and Innovation Committee
The following analysts evaluate the performance of Medartis stock and the investment opportunities for investors.
Mr Daniel Buchta
Bryan Garnier & Co.
Mr. Dylan van Haaften
26 Avenue des Champs-Elysées
Frau Tanya Hansalik
Would you like to be informed about Medartis at first hand? Register and receive our news in electronic form.
Head of Corporate Communications
Journalists and members of the media:
Shareholders and investors: